Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 145572-44-7 Chemical Structure| 145572-44-7

Structure of Sophocarpine monohydrate
CAS No.: 145572-44-7

Chemical Structure| 145572-44-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sophocarpine, a natural product isolated and purified from the herb of Sophora alopecuroidos L., with anti-viral, anti-cachectic and anti-inflammatory effects, can alleviate liver fibrosis mainly by inhibiting the TLR4 pathway, it may be a potential chemotherapeutic agent for chronic liver diseases, ameliorate the ischemic injury induced by transient focal cerebral ischemia in rats and that this neuroprotective effect may be related to the anti-ASIC1 channel and anti-apoptotic action of sophocarpine, and also alleviate hepatocyte steatosis and the potential mechanism may be the activated signaling pathway of AMPK.

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sophocarpine monohydrate

CAS No. :145572-44-7
Formula : C15H24N2O2
M.W : 264.36
SMILES Code : O=C1C=CC[C@]2([H])[C@@]3([H])CCCN4[C@@]3([H])[C@](CCC4)([H])CN21.[H]O[H]
English Name :(41S,7aS,13aR,13bR)-2,3,41,6,7,7a,8,13,13a,13b-Decahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one hydrate
MDL No. :MFCD26960838

Safety of Sophocarpine monohydrate

Related Pathways of Sophocarpine monohydrate

epigenetics
MAPK
PI3K-AKT
pyroptosis

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
UM-SCC-47 cells 1 μM, 2 μM, 4 μM 24 hours To evaluate the effect of Sophocarpine on miR-21 expression, results showed that Sophocarpine downregulated miR-21 expression in a dose-dependent manner. Mol Ther. 2017 Sep 6;25(9):2129-2139.
UM-SCC-22B cells 1 μM, 2 μM, 4 μM 24 hours To evaluate the effect of Sophocarpine on miR-21 expression, results showed that Sophocarpine downregulated miR-21 expression in a dose-dependent manner. Mol Ther. 2017 Sep 6;25(9):2129-2139.
UM-SCC-47 cells 1.536 μM (IC50) 48 hours To evaluate the inhibitory effect of Sophocarpine on HNSCC cell proliferation, results showed that Sophocarpine inhibited cell proliferation in a dose-dependent manner. Mol Ther. 2017 Sep 6;25(9):2129-2139.
UM-SCC-22B cells 1.067 μM (IC50) 48 hours To evaluate the inhibitory effect of Sophocarpine on HNSCC cell proliferation, results showed that Sophocarpine inhibited cell proliferation in a dose-dependent manner. Mol Ther. 2017 Sep 6;25(9):2129-2139.
Bone marrow-derived macrophages (BMM) 0.25, 0.50, 1.00 mM 48 hours Evaluate the effect of SPC on bone resorption, results showed dose-dependent reduction in bone resorption area Br J Pharmacol. 2018 Mar;175(6):859-876.
Bone marrow-derived macrophages (BMM) 0.31-2 mM 48 or 96 hours Evaluate the effect of SPC on BMM cell viability, results showed no cytotoxicity up to 2 mM Br J Pharmacol. 2018 Mar;175(6):859-876.
Neonatal rat ventricular myocytes 10 μmol/L 3 minutes To study the effects of sophocarpine on sodium current, results showed that sophocarpine significantly inhibited sodium current. Acta Pharmacol Sin. 2011 Mar;32(3):311-20.
Rabbit sinus node cells 0.1-1 μmol/L To study the effects of sophocarpine on slow response action potentials, results showed that sophocarpine decreased APA and Vmax and prolonged APD. Acta Pharmacol Sin. 2011 Mar;32(3):311-20.
Guinea pig papillary muscle cells 1-100 μmol/L 8-10 minutes To study the effects of sophocarpine on fast response action potentials, results showed that sophocarpine dose-dependently prolonged APD and ERP and decreased APA and Vmax. Acta Pharmacol Sin. 2011 Mar;32(3):311-20.
Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) 2, 10, 50 μM 24 hours To evaluate the effects of sophocarpine on impedance and extracellular field potential (EFP) in cardiomyocytes. Results showed that sophocarpine dose-dependently affected both impedance and EFP, related to disruption of calcium homeostasis and oxidative stress. in human pluripotent stem cell-derived cardiomyocytes. Stem Cell Res Ther.
Rat aortic endothelial cells (RAECs) 0.0625, 0.125, 0.25, 0.5, 1.0, 2.0 mmol/L 48 hours To evaluate the protective effects of Sophocarpine on AGEs-induced oxidative stress and apoptosis. Results showed that Sophocarpine significantly suppressed AGEs-induced ROS production and apoptosis, restored phosphorylation of MKK3/6 and p38 MAPK, and promoted Nrf2 nuclear translocation and ARE binding activity. J Am Heart Assoc. 2017 Dec 2;6(12):e007441.

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice UM-SCC-22B xenograft model Intravenous injection 5 mg/kg Every other day for 21 days To evaluate the inhibitory effect of Sophocarpine on tumor growth in vivo, results showed that Sophocarpine significantly inhibited tumor growth without observable tissue toxicity. Mol Ther. 2017 Sep 6;25(9):2129-2139.
Sprague-Dawley rats Titanium particle-induced femoral implant loosening model Intraperitoneal injection 20 mg/kg/day Once daily for 4 or 12 weeks Evaluate the preventive effect of SPC on titanium particle-induced implant loosening, results showed SPC inhibited osteoclast formation, reduced pseudomembrane formation, improved bone-implant contact, and enhanced implant stability Br J Pharmacol. 2018 Mar;175(6):859-876.
Guinea pigs Isoprenaline-induced arrhythmia model Perfusion 300 μmol/L Single administration, lasting 11-17 minutes To study the effects of sophocarpine on isoprenaline-induced arrhythmia, results showed that sophocarpine reversed arrhythmia and decreased heart rate. Acta Pharmacol Sin. 2011 Mar;32(3):311-20.
Sprague-Dawley rats AGEs-induced aortic endothelial cell injury model Intraperitoneal injection 40 mg/kg/day Once daily for 10 consecutive days To evaluate the protective effects of Sophocarpine on AGEs-induced oxidative stress and apoptosis in aortic endothelial cells. Results showed that Sophocarpine significantly suppressed AGEs-induced ROS production and apoptosis, restored phosphorylation of MKK3/6 and p38 MAPK, and promoted Nrf2 nuclear translocation and antioxidant enzyme expression. J Am Heart Assoc. 2017 Dec 2;6(12):e007441.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.78mL

0.76mL

0.38mL

18.91mL

3.78mL

1.89mL

37.83mL

7.57mL

3.78mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories